• OPEN AN ACCOUNT
Indian Indices
Sensex
78,581.00 152.05
( 0.19%)
Global Indices
Nasdaq
54,113.09 913.68
(1.72%)
Dow Jones
7,758.57 137.07
(1.80%)
Hang Seng
66,265.57 2,308.04
(3.61%)
Nikkei 225
10,890.39 32.69
(0.30%)
Forex
USD-INR
95.29 -0.10
(-0.11%)
EUR-INR
109.78 -0.22
(-0.20%)
GBP-INR
128.18 -0.43
(-0.33%)
JPY-INR
0.61 0.00
(0.31%)

EQUITY - MARKET SCREENER

Parenteral Drugs (India) Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524689
INE904D01019
-300.6045095
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PDPL
0
10.11
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

saregama india ltd
Genesys International Corporation consolidated net profit declines 34.78% in the March 2026 quarter
Jun 01,2026
Net profit of Genesys International Corporation declined 34.78% to Rs 12.36 crore in the quarter ended March 2026 as against Rs 18.95 crore during the previous quarter ended March 2025. Sales rose 10.68% to Rs 104.22 crore in the quarter ended March 2026 as against Rs 94.16 crore during the previous quarter ended March 2025.

For the full year,net profit declined 42.05% to Rs 32.58 crore in the year ended March 2026 as against Rs 56.22 crore during the previous year ended March 2025. Sales rose 5.39% to Rs 327.81 crore in the year ended March 2026 as against Rs 311.03 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales104.2294.16 11 327.81311.03 5
OPM %32.7252.86 -33.3645.69 -
PBDT34.2046.80 -27 116.57137.70 -15
PBT17.0931.52 -46 51.5982.68 -38
NP12.3618.95 -35 32.5856.22 -42